Loading…

Evaluation radioprotective effect of curcumin conjugated albumin nanoparticles

[Display omitted] •Preparation of Curcumin conjugated albumin nanoparticles (BSA-CUR) as radioprotection agent.•Incorporation of CUR into BSA was improved chemical stability of it.•Hazard Ratio (Mantel-Haenszel) of BSA-CUR treated groups are lower than control group.•The BSA-CUR can use as a profici...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic chemistry 2020-07, Vol.100, p.103891, Article 103891
Main Authors: Nosrati, Hamed, Danafar, Hossein, Rezaeejam, Hamed, Gholipour, Nazila, Rahimi-Nasrabadi, Mehdi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] •Preparation of Curcumin conjugated albumin nanoparticles (BSA-CUR) as radioprotection agent.•Incorporation of CUR into BSA was improved chemical stability of it.•Hazard Ratio (Mantel-Haenszel) of BSA-CUR treated groups are lower than control group.•The BSA-CUR can use as a proficient vehicle for improve potential radioprotective effect of CUR. In this research, curcumin (CUR) conjugated albumin based nanoparticles (BSA-CUR) were designed for improvement and evaluation radioprotective effect of CUR. In this way, we have prepared BSA-CUR by covalently binding the CUR with BSA. Next, this synthesized prodrug was evaluated for physical and chemical properties by Fourier-transform infrared (FTIR), Dynamic light scattering (DLS), Transmission electron microscopy (TEM), Ultraviolet–visible (UV/Vis), and Differential scanning calorimetry (DSC) analysis. Furthermore, the chemical stability of designed prodrug was appraised. The result shows that the size of nanoparticles is 174.4 nm with a polydispersity index (PdI) of 0.191. The nanoparticles have a high loading capacity and show sustained release behavior. Loading of CUR to BSA not only could increase the chemical stability of CUR, but also could improve radioprotection efficacy of it's against X-Ray irradiation. The HHF-2 cells show 107% viability in the presence of BSA-CUR at a concentration of 50 µg/mL, whereas non-treated cells show 46% viability, under X-Ray irradiation. Also in vivo study results show that, four out of five mice have died when the mice irradiated by X-Ray and no received any treatment. Although, for a group that treated with BSA-CUR and also irradiated by X-Ray, median survival and survival rate was higher than CUR treated and control mice, and only two out of five mice have died. The result of this study proved that BSA-CUR can be used as a proficient vehicle for improving the potential radioprotective effect of CUR.
ISSN:0045-2068
1090-2120
DOI:10.1016/j.bioorg.2020.103891